Curis, Inc. (CRIS)
1.285
-0.02
(-1.15%)
USD |
NASDAQ |
Dec 11, 16:00
1.285
0.00 (0.00%)
After-Hours: 18:00
Curis EPS Diluted (Quarterly): -0.4929 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| AIM ImmunoTech, Inc. | -1.569 |
| Perspective Therapeutics, Inc. | -0.3495 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
| Electromed, Inc. | 0.246 |
| Armata Pharmaceuticals, Inc. | -0.7363 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.729M |
| Revenue (Quarterly) | 3.176M |
| Total Expenses (Quarterly) | 10.90M |
| Enterprise Value | 38.36M |
| Gross Profit Margin (Quarterly) | 98.52% |
| Profit Margin (Quarterly) | -243.4% |
| Earnings Yield | -286.1% |
| Normalized Earnings Yield | -286.15 |